SHR-A1811 Combine With Pyrotinib for Locally Advanced/Metastatic HER2 Positive Breast Cancer
Clinical trial NCT07132242 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07132242
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-30
- Primary completion
- 2028-08-30
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.